Trial Profile
A study of interferon-beta in combination with immunotherapy for the treatment of malignant melanoma
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 03 Aug 2016
Price :
$35
*
At a glance
- Drugs Immunotherapies (Primary) ; Interferon beta (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 03 Aug 2016 New trial record